ClinicalTrials.gg
CompletedNCT07619690TAMEUpdated Nov 18, 2026

Teen Anger Management (TAME) in Portugal

An interventional study of Teen Anger Management Education in Anger, sponsored by University of Beira Interior. Completed at 1 site in Portugal. Open to participants aged 11 Years to 16 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by University of Beira Interior · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Dec 2025, registered May 2026).
Updated Nov 18, 2026Now CompletedTitle changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
11 Years to 16 Years
Sex
All
01

Study summary

This study aims to (1) explore the preliminary effectiveness outcomes of the Teen Anger Management Education (TAME) program among Portuguese adolescents and to (2) inform sample size considerations for a future large-scale trial.

02

Conditions studied

  • Anger

Keywords

  • anger management
  • social skills
  • emotion regulation
  • adolescents
03

In context

Social Skills

122 studies on the registry are indexed under Social Skills; 31 are open to participants now.

This study's enrollment of 56 is below the median of 78 across 112 interventional studies indexed under Social Skills.

Browse Social Skills studies →

Lead sponsor

University of Beira Interior is the lead sponsor of 15 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Frequent maladaptive anger responses and/or rare adaptive anger responses

Exclusion criteria

Exclusion Criteria:

  • Ongoing psychological treatment
  • Diagnosis of schizophrenia or cognitive deficits
  • Substance abuse problems
  • Inability to speak and understand the Portuguese language
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    Intervention groups

    The intervention groups receive the TAME intervention.

    Behavioral: Teen Anger Management Education

  • No intervention
    Control groups

    The control groups are on a waiting list to receive the TAME intervention.

Interventions

  • BehavioralTeen Anger Management Education

    TAME was developed in the United States of America (Feindler \& Gerber, 2008; Feindler \& Sita-Molz, 2021). This is a 12-session intervention program designed for use with early to late adolescents (ages 12-17).

    Also known as: TAME

06

What researchers measure

Primary outcomes

  1. Anger Regulation Scale for Adolescents (ARS-A)

    Assesses functional and dysfunctional anger regulation. The scale ranges from 1 (Never) to 4 (Always), with higher scores indicating more frequent use of adaptive or maladaptive strategies.

    Time frame: Change from baseline (4 months after baseline), 3 months after treatment has ended, and 6 months after treatment has ended.

Secondary outcomes

  1. Caregiver Anger Rating Scale

    Assesses caregiver perceptions of child/adolescent anger responses. The scale ranges from 1 (\[Almost\] Never) to 5 (\[Almost\] Always), with higher scores indicating more frequent use of adaptive or maladaptive anger responses.

    Time frame: Change from baseline (about 4 months after treatment had ended).

  2. Teacher Anger Rating Scale

    Assesses teacher perceptions of child/adolescent anger responses. The scale ranges from 1 (\[Almost\] Never) to 5 (\[Almost\] Always), with higher scores indicating more frequent use of adaptive or maladaptive anger responses.

    Time frame: Change from baseline (about 4 months after treatment had ended).

Other outcomes

  1. Satisfaction questionnaire

    Adolescents rate their levels of treatment satisfaction. The scale ranges from 1 (I completely disagree) to 7 (\[I completely agree), with higher scores indicating more satisfaction.

    Time frame: At the end of the program (about 4 months after baseline).

07

Study locations

1 site
  • Department of Psychology and Education, University of Beira Interior
    Covilha, 6200-209, Portugal
08

References and documents

Publications

  • Feindler, E. L., & Gerber, M. F. (2008). TAME: Teen Anger Management Education. In C. W. LeCroy (Ed.), Handbook of evidence-based treatment manuals for children and adolescents (2nd ed., pp. 139-169). Oxford University Press.
  • Feindler, E. L., & Sita-Molz, G. (2021). Teen Anger Management Education: Implementation guidelines for counselors. Research Press.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2025 to primary completion in Oct 2026, 10 months.

Of 70 non-industry interventional studies with no phase under Social Skills, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's 10 months is below that.

Counting every sponsor, half of 74 studies reached it within 22 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
May 26, 2026
First posted
Jun 2, 2026
StartActual
Dec 2, 2025
Primary completionActual
Oct 30, 2026
CompletionActual
Oct 30, 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 18, 2026
Title
Teen Anger Management Education (TAME): Effectiveness of the Portuguese Adaptation in Portugal
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Active, not recruiting→Completed
    Title Teen Anger Management Education (TAME): Effectiveness of the Portuguese Adaptation in Portugal
    + 4 other changes: date precision, description, arm descriptions and references

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07619690
Lead sponsor
University of Beira Interior
Responsible party
Fernanda Guedes (Principal Investigator, University of Beira Interior) — Principal investigator
First posted
Jun 2, 2026
Start date
Dec 2, 2025
Primary completion
Oct 30, 2026
Completion
Oct 30, 2026
Last update
Nov 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion